Moderna vs Sinopia Biosciences
Moderna vs Sinopia Biosciences, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Moderna is on 77/100 and Sinopia Biosciences on 54/100.
Where each one leads
Moderna
- our overall score: 77/100 against 54/100
- agent readiness: 49/100 against 40/100
- domain rating: 79/100 against 10/100
- funding raised: $4.5B against $2.2M
Sinopia Biosciences
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Moderna | Sinopia Biosciences |
|---|---|---|
| What it is | Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics. | Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform. |
| Category | Biotechnology, mRNA Technology, Vaccines, Pharmaceuticals | Biotechnology, Drug Discovery, Oncology, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2010 | 2017 |
| Headquarters | Cambridge, United States | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Moderna | Sinopia Biosciences |
|---|---|---|
| Employees | 6,297 | Not published |
| Open roles | 100 | Not published |
| Total funding | $4.5B | $2.2M |
| Latest round | Funding Round | Grant |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 780,086 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Moderna | Sinopia Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 77/100 | 54/100 |
| Traction | 60/100 | 32/100 |
| Team | 70/100 | 70/100 |
| Community | 13/100 | Not published |
| Search visibility | 46/100 | 15/100 |
| Quality | 90/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (49/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 79/100 | 10/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Moderna | Sinopia Biosciences |
|---|---|---|
| Hosting | AWS | Not detected |
| CDN | CloudFront | Not detected |
| CMS | Not detected | Squarespace |
| Frameworks | Next.js | Not detected |
What users say
| Measure | Moderna | Sinopia Biosciences |
|---|---|---|
| Community ratingVisitor votes on StartupHub | 2.0/5 from 1 vote | Not published |
Moderna vs Sinopia Biosciences: common questions
Which is better, Moderna or Sinopia Biosciences?
On our 0-100 score Moderna rates higher (77/100 against 54/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Moderna and Sinopia Biosciences compare on the numbers?
Moderna leads on our overall score (77/100 against 54/100), agent readiness (49/100 against 40/100), domain rating (79/100 against 10/100), funding raised ($4.5B against $2.2M).
Read the full Moderna review and pricing or the Sinopia Biosciences review and pricing. You can also browse other Moderna alternatives we track.